[Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
Zheludkova
O G
OG
Tarasova
I S
IS
Gorbatykh
S V
SV
Belogurova
M B
MB
Kumirova
E V
EV
Borodina
I D
ID
Prityko
A G
AG
Melikian
A G
AG
Shcherbenko
O I
OI
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy* / Q000401:mortality; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000401:mortality; D020295:Brain Stem Neoplasms / Q000188:drug therapy / Q000401:mortality; D002528:Cerebellar Neoplasms / Q000188:drug therapy / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D000077204:Temozolomide; D013997:Time Factors
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide